Cargando…
The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20‐Year Data from the U.S. Glatiramer Acetate Extension Study
BACKGROUND AND PURPOSE: Conventional MRI techniques do not necessarily provide information about multiple sclerosis (MS) disease pathology or progression. Nonconventional MRI techniques, including proton magnetic resonance spectroscopy ((1)H‐MRS), are increasingly used to improve the qualitative and...
Autores principales: | Khan, Omar, Seraji‐Bozorgzad, Navid, Bao, Fen, Razmjou, Sara, Caon, Christina, Santiago, Carla, Latif, Zahid, Aronov, Rimma, Zak, Imad, Ashtamker, Natalia, Kolodny, Scott, Ford, Corey, Sidi, Yulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248608/ https://www.ncbi.nlm.nih.gov/pubmed/27214389 http://dx.doi.org/10.1111/jon.12358 |
Ejemplares similares
-
Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis
por: Bernitsas, Evanthia, et al.
Publicado: (2017) -
Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study
por: Davis, Mat D., et al.
Publicado: (2017) -
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study
por: Rieckmann, Peter, et al.
Publicado: (2021) -
Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018) -
Characterizing Fatigue-Related White Matter Changes in MS: A Proton Magnetic Resonance Spectroscopy Study
por: Yarraguntla, Kalyan, et al.
Publicado: (2019)